嘉应制药：累计回购约1040万股

Group 1 - Company announced the completion of a share repurchase program, acquiring approximately 10.4 million shares, which represents 2.048% of the total share capital, with a total transaction amount of about 69.99 million yuan [1] - The highest transaction price during the repurchase was 7.04 yuan per share, while the lowest was 5.96 yuan per share [1] - For the first half of 2025, the company's revenue composition shows that the pharmaceutical industry accounted for 99.96%, with other businesses making up 0.04% [1] Group 2 - The current market capitalization of the company is 3.2 billion yuan [2]